2008
DOI: 10.1183/09031936.00153207
|View full text |Cite
|
Sign up to set email alerts
|

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?

Abstract: The balance between inflammatory and repair processes is important in maintaining lung homeostasis in chronic obstructive pulmonary disease (COPD). The aim of the present study was to determine whether or not an integrated index of a biomarker involved in inflammation, C-reactive protein (CRP), and another involved in wound repair, fibronectin, may be a good measure to predict clinical outcomes in COPD.Circulating blood levels of CRP and fibronectin were measured in 4,787 individuals with mild-tomoderate COPD … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
44
0
5

Year Published

2008
2008
2015
2015

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 57 publications
(49 citation statements)
references
References 38 publications
0
44
0
5
Order By: Relevance
“…The research by MAN et al [1] is opportunistic as data were collected for a different purpose in an original clinical trial [5], so the study in the present issue of the ERJ has intrinsic limitations, some of them already highlighted by the authors. As in any cross-sectional analysis, causality cannot be inferred.…”
mentioning
confidence: 99%
See 3 more Smart Citations
“…The research by MAN et al [1] is opportunistic as data were collected for a different purpose in an original clinical trial [5], so the study in the present issue of the ERJ has intrinsic limitations, some of them already highlighted by the authors. As in any cross-sectional analysis, causality cannot be inferred.…”
mentioning
confidence: 99%
“…In a ratio of fibronectin to CRP, this could happen either through a higher fibronectin concentration (more repair) or through a lower CRP (less inflammation). Naturally, the study by MAN et al [1] is hypothesis-generating and deserves to be tested in other samples of COPD individuals with a more varied severity and from different settings.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Changes in the concentration of fibronectin in tissues and body fluids have been reported in various disease conditions. For example elevated levels of fibronectin have been found in plasma of patients with rheumatoid vasculitis [2], collagen vascular diseases, diabetes mellitus [3], chronic obstructive pulmonary disease [4], ischemic heart disease [5], renal cancer [6], gastrointestinal cancer [7], acute myocardiac infarction [8], coronary artery disease [9] and trauma [10]. Increased levels of fibronectin in plasma of patients with some of these conditions were attributed to increased synthesis caused by proinflammatory cytokines, and release of extracelluar matrix and cell surface fibronectins into circulating plasma [3].…”
Section: Introductionmentioning
confidence: 99%